BOSTON, Nov. 10, 2010 /PRNewswire/ -- China PharmaHub Corp. (OTC Bulletin Board: CPHB) ("PharmaHub") announced it has signed an agreement to be a distributor for Integrated Biometrics ("IB"), a provider of high performance fingerprint biometric identity solutions. PharmaHub will have the exclusive distribution rights in China, Hong Kong, Taiwan and Macau (the "Greater China Region") to sell IB products to customers in the Pharmaceutical, Biotechnology, Healthcare, Lock Manufacturing and Safe Manufacturing industries. Additionally, PharmaHub will have the non-exclusive right to sell such products to other industries in the Greater China Region.
IB develops and manufactures fingerprint-based biometric identification systems which result in highly dependable logical and physical access control solutions. IB's patented Light Emitting Sensor technology is the cutting edge in biometric fingerprint identification and provides a superior combination of security, usability and durability. With China's biometrics market growing at a rate of 50% per annum, its market is expected to reach 3 billion RMB by the end of 2010, PharmaHub and IB believe they are well-positioned to capitalize on this growing market.
Richard Lui, President of PharmaHub, said "We are very excited to be working with industry leaders such as IB. PharmaHub's growing distribution channel of 2,600 hospitals and ties to China's healthcare industry present very exciting opportunities for sales of IB products. Working with successful companies such as Integrated Biometrics embodies the PharmaHub model."
Lui concluded, "We started PharmaHub with the goal of eventually becoming a global pharmaceutical 'HUB'. Since the founding of PharmaHub in July 2009, we have worked non-stop to build a foundation of strategic alliances, partnerships and joint ventures."
|SOURCE China PharmaHub Corp.|
Copyright©2010 PR Newswire.
All rights reserved